Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor
about
Mutations in the RUNX2 gene in patients with cleidocranial dysplasiaCbfa1/RUNX2 directs specific expression of the sclerosteosis gene (SOST)A proximal activator of transcription in epithelial-mesenchymal transitionIdentification of a new pebp2alphaA2 isoform from zebrafish runx2 capable of inducing osteocalcin gene expression in vitro.Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma.The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts.Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D-responsive transcription and contribute to chromatin organization.Hypoxia inhibits osteogenesis in human mesenchymal stem cells through direct regulation of RUNX2 by TWISTTwist controls skeletal development and dorsoventral patterning by regulating runx2 in zebrafish.Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia.Use of small interfering ribonucleic acids to inhibit the adipogenic effect of alcohol on human bone marrow-derived mesenchymal cellsThe Role of RUNX2 in Osteosarcoma Oncogenesis.Identification of putative target genes of the transcription factor RUNX2.Bone tissue engineering: recent advances and promising therapeutic agents.Mesothelial cell differentiation into osteoblast- and adipocyte-like cells.Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat.Runx2 and dental development.RUNX2 mutations in Chinese patients with cleidocranial dysplasia.Dose-dependent effects of Runx2 on bone development.Regulation of collagenase-3 gene expression in osteoblastic and non-osteoblastic cell lines.AML3/CBFalpha1 is required for androgen-specific activation of the enhancer of the mouse sex-limited protein (Slp) gene.Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation.Cbfa1 isoforms exert functional differences in osteoblast differentiation.Mouse embryo-derived NIH3T3 fibroblasts adopt an osteoblast-like phenotype when treated with 1alpha,25-dihydroxyvitamin D(3) and dexamethasone in vitro.Initial Characterization of Osteoblast Differentiation and Loss of RUNX2 Stability in the Newly Established SK11 Human Embryonic Stem Cell-Derived Cell Line.A variant of Runx2 that differs from the bone isoform in its splicing is expressed in spermatogenic cells.Characterization of an osteoblast-specific enhancer element in the CBFA1 gene.Characterization of the upstream mouse Cbfa1/Runx2 promoter.Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts.Parathyroid hormone regulation of the rat collagenase-3 promoter by protein kinase A-dependent transactivation of core binding factor alpha1.Effects of soluble silicon compound and deep-sea water on biochemical and mechanical properties of bone and the related gene expression in mice.Endogenous bone morphogenetic proteins mediate 1alpha, 25-dihydroxyvitamin D(3)-induced expression of osteoblast differentiation markers in human dermal fibroblasts.The regulatory landscape of osteogenic differentiation.Inhibitory effect of alcohol on osteogenic differentiation in human bone marrow-derived mesenchymal stem cells.Synthetic octacalcium phosphate-enhanced reparative dentine formation via induction of odontoblast differentiation.Runx2/Cbfa1-genetically engineered skeletal myoblasts mineralize collagen scaffolds in vitro.Integrin-associated tyrosine kinase FAK affects Cbfa1 expression.Family-based association study of polymorphisms in the RUNX2 locus with hand bone length and hand BMD.Selective deficiency of the "bone-related" Runx2-II unexpectedly preserves osteoblast-mediated skeletogenesis.A computationally identified compound antagonizes excess FGF-23 signaling in renal tubules and a mouse model of hypophosphatemia.
P2860
Q28202887-B906AD3F-53A9-47FD-BFB4-57F52248C1B2Q28240192-B2609879-1666-4D63-9A33-291A902A5CD8Q28588516-C2A89930-F9C1-4B26-96BB-7BA0E796F24BQ33341337-1CAB9E44-A7CC-429D-B68C-D4095944EF9AQ33623477-0412D952-AB85-46B1-8745-475E705F82B6Q33953806-C83DFDA6-1C8D-4276-9B0E-540655D3178CQ33960022-A8F88F64-0828-4EF8-8896-396B53277589Q34023208-0C220F2F-2AF2-47B6-814A-9DAEDBA4D727Q34075607-AAE0A423-EBA7-4E54-906A-5D797F4C08CFQ34145893-4D30A7F2-34CB-4C3C-BDCD-62ADB176E307Q34336984-63F356EB-D23D-4379-B53F-AE2F3346413FQ34423871-3C8590CB-7AB4-4E1F-8FCB-C3A5574BB5E7Q35070834-31DF3D3C-A760-45FA-A500-4064D39FDBDDQ35144021-C7C3F0FF-532D-41C0-8ACB-0DB474716CC3Q35377318-9BDBC71B-5AEC-4FA5-9C54-A0E8C3E017E0Q35745608-BE56427D-E358-4CE7-87E4-CE01DCEE22D3Q36616577-17BFBA33-2E7A-47D8-95AE-F9E5E9E8FE36Q37325296-B8969DC6-861E-4FC4-AB46-09A18D57C332Q37396635-341083D8-A31E-4469-B50A-EAA4C775A5DBQ38308789-768CD881-009C-4719-A01E-3D0362203FDCQ38319507-05260DAE-4984-4CAB-B0EA-39996DE1E458Q38324655-5BDAF59B-C6D1-4751-A794-908AC1C7A770Q38327457-DB20E99F-645B-48A3-BDE8-7884DD12F371Q38361843-6E78587D-C9D9-4813-863F-C78D507640DFQ38962535-E20CA930-1448-4BBC-A8C7-4D739B83B509Q39968436-FA510CC4-BA76-485F-BFEB-00433BE20332Q40709828-2A6A9883-05B5-4D1A-9833-29746402F081Q40786632-E844749D-59D3-4876-8C16-2FFF20A8798CQ40834929-A03BF122-32CC-4955-BD94-0A20B3C7AB69Q40900508-98CA9EE5-355A-42BE-A849-BAE2D0156A4FQ42808968-BC28261F-6E12-4EC2-9C1D-C89CCCF92060Q43198337-026FDD44-4CA3-4A94-BBFA-C221621BB2CEQ43660854-EE96CFE1-EF06-4C53-8D47-7FE2035A0128Q44845138-51FA37F0-E3F8-41C0-8913-E73FD20C9C0AQ45735364-990E501F-2B57-4E4F-B67B-E791E6EB9400Q46284858-A4DD5C15-B7F9-47D1-B859-9369D32F4A19Q46294340-A36168CF-975B-4351-B256-E180C5A1E76DQ47699681-7CBA604E-1E03-4CD5-8C1A-E082AC173051Q47985451-CFC3683A-42BE-46A9-B0A8-2CF70DA1F3E5Q51308109-96FB37AE-4C56-47BD-81CA-2C78EEC7E7A7
P2860
Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor
description
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1998
@ast
im Juli 1998 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1998/07/03)
@sk
vědecký článek publikovaný v roce 1998
@cs
wetenschappelijk artikel (gepubliceerd op 1998/07/03)
@nl
наукова стаття, опублікована в липні 1998
@uk
مقالة علمية (نشرت في 3-7-1998)
@ar
name
Genomic structure and isoform ...... bfa1/Osf2 transcription factor
@ast
Genomic structure and isoform ...... bfa1/Osf2 transcription factor
@en
Genomic structure and isoform ...... bfa1/Osf2 transcription factor
@nl
type
label
Genomic structure and isoform ...... bfa1/Osf2 transcription factor
@ast
Genomic structure and isoform ...... bfa1/Osf2 transcription factor
@en
Genomic structure and isoform ...... bfa1/Osf2 transcription factor
@nl
prefLabel
Genomic structure and isoform ...... bfa1/Osf2 transcription factor
@ast
Genomic structure and isoform ...... bfa1/Osf2 transcription factor
@en
Genomic structure and isoform ...... bfa1/Osf2 transcription factor
@nl
P2093
P3181
P1433
P1476
Genomic structure and isoform ...... bfa1/Osf2 transcription factor
@en
P2093
L. D. Quarles
T. K. Hinson
Z. S. Xiao
P304
P3181
P356
10.1016/S0378-1119(98)00227-3
P407
P577
1998-07-03T00:00:00Z